Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eduardo Rodriguez Almaraz

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Treatment Options in Oncology|January 12, 2023
Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis)J Eduardo Rodriguez-Almaraz, Nicholas Butowski
Neuro-Oncology Practice|May 11, 2026
Creating a neuro-oncology framework for an empowered and engaged peer volunteer patient communityNaomi Hoffer, Eduardo Rodriguez Almaraz, Lacy Fetting, et al.
NPJ Digital Medicine|April 3, 2024
Evaluating large language models as agents in the clinicNikita Mehandru, Brenda Y Miao, Eduardo Rodriguez Almaraz, et al.
Neuro-Oncology Practice|February 7, 2025
Reporting standards in randomized controlled trials involving neuro-oncology caregivers: A systematic review report from the RANO-Cares working groupFlorien W Boele, Caroline Hertler, Paula Sherwood, et al.
Neuro-Oncology Practice|August 9, 2020
A systematic review and meta-analysis examining the effects of cannabis and its derivatives in adults with malignant CNS tumorsJesus-Eduardo Rodriguez-Almaraz, Susan Chang, Jennifer Clarke, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomideGeno Guerra, George Wendt, Lucie McCoy, et al.
Neuro-Oncology|January 2, 2025
Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomideGeno Guerra, George Wendt, Lucie McCoy, et al.
Neuro-Oncology Advances|March 7, 2025
Longitudinal profiling of IDH-mutant astrocytomas reveals acquired RAS-MAPK pathway mutations associated with inferior survivalEduardo Rodriguez Almaraz, Geno A Guerra, Nadeem N Al-Adli, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Treatment Options in Oncology|January 12, 2023
Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis)J Eduardo Rodriguez-Almaraz, Nicholas Butowski
Neuro-Oncology Practice|May 11, 2026
Creating a neuro-oncology framework for an empowered and engaged peer volunteer patient communityNaomi Hoffer, Eduardo Rodriguez Almaraz, Lacy Fetting, et al.
NPJ Digital Medicine|April 3, 2024
Evaluating large language models as agents in the clinicNikita Mehandru, Brenda Y Miao, Eduardo Rodriguez Almaraz, et al.
Neuro-Oncology Practice|February 7, 2025
Reporting standards in randomized controlled trials involving neuro-oncology caregivers: A systematic review report from the RANO-Cares working groupFlorien W Boele, Caroline Hertler, Paula Sherwood, et al.
Neuro-Oncology Practice|August 9, 2020
A systematic review and meta-analysis examining the effects of cannabis and its derivatives in adults with malignant CNS tumorsJesus-Eduardo Rodriguez-Almaraz, Susan Chang, Jennifer Clarke, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomideGeno Guerra, George Wendt, Lucie McCoy, et al.
Neuro-Oncology|January 2, 2025
Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomideGeno Guerra, George Wendt, Lucie McCoy, et al.
Neuro-Oncology Advances|March 7, 2025
Longitudinal profiling of IDH-mutant astrocytomas reveals acquired RAS-MAPK pathway mutations associated with inferior survivalEduardo Rodriguez Almaraz, Geno A Guerra, Nadeem N Al-Adli, et al.
Pageof 1